Human Molecular Genetics Advance Access originally published online on November 24, 2004
Human Molecular Genetics 2005 14(2):241-253; doi:10.1093/hmg/ddi022
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Human Molecular Genetics, Vol. 14, No. 2 © Oxford University Press 2005; all rights reserved
Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis
Laboratory for Molecular Dynamics of Mental Disorders, Brain Science Institute, RIKEN, Wako, Saitama 351-0198, Japan
* To whom correspondence should be addressed at: Laboratory for Molecular Dynamics of Mental Disorders, Brain Science Institute, RIKEN, Hirosawa 2-1, Wako, Saitama 351-0198, Japan. Tel: +81 484676949; Fax: +81 484676947; Email: kato{at}brain.riken.go.jp
Received August 18, 2004; Revised October 15, 2004; Accepted November 9, 2004
Accumulating evidence suggests that mitochondrial dysfunction underlies the pathophysiology of bipolar disorder (BD) and schizophrenia (SZ). We performed large-scale DNA microarray analysis of postmortem brains of patients with BD or SZ, and examined expression patterns of mitochondria-related genes. We found a global down-regulation of mitochondrial genes, such as those encoding respiratory chain components, in BD and SZ samples, even after the effect of sample pH was controlled. However, this was likely due to the effects of medication. Medication-free patients with BD showed tendency of up-regulation of subset of mitochondrial genes. Our findings support the mitochondrial dysfunction hypothesis of BD and SZ pathologies. However, it may be the expression changes of a small fraction of mitochondrial genes rather than the global down-regulation of mitochondrial genes. Our findings warrant further study of the molecular mechanisms underlying mitochondrial dysfunction in BD and SZ.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. Malkesman, D. R. Austin, G. Chen, and H. K. Manji Reverse translational strategies for developing animal models of bipolar disorder Dis. Model. Mech., May 1, 2009; 2(5-6): 238 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lieberman, F. P. Bymaster, H. Y. Meltzer, A. Y. Deutch, G. E. Duncan, C. E. Marx, J. R. Aprille, D. S. Dwyer, X.-M. Li, S. P. Mahadik, et al. Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection Pharmacol. Rev., September 1, 2008; 60(3): 358 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iwamoto and T. Kato Gene Expression Profiling in Schizophrenia and Related Mental Disorders Neuroscientist, August 1, 2006; 12(4): 349 - 361. [Abstract] [PDF] |
||||
![]() |
N. Nakatani, E. Hattori, T. Ohnishi, B. Dean, Y. Iwayama, I. Matsumoto, T. Kato, N. Osumi, T. Higuchi, S.-I. Niwa, et al. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation Hum. Mol. Genet., June 15, 2006; 15(12): 1949 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iwamoto, M. Bundo, K. Yamada, H. Takao, Y. Iwayama-Shigeno, T. Yoshikawa, and T. Kato DNA Methylation Status of SOX10 Correlates with Its Downregulation and Oligodendrocyte Dysfunction in Schizophrenia J. Neurosci., June 1, 2005; 25(22): 5376 - 5381. [Abstract] [Full Text] [PDF] |
||||




